Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
Insler
S R
SR
Department of Cardiothoracic Anesthesia, Cleveland Clinic Foundation, Ohio 44195, USA.
Kraenzler
E J
EJ
Bartholomew
J R
JR
Kottke-Marchant
K
K
Lytle
B
B
Starr
N J
NJ
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D002809:Chondroitin Sulfates / Q000009:adverse effects*; D003871:Dermatan Sulfate / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced*
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid